Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,357,027,741
-$23,431,758 QoQ
Shares Held
5,343,260
-5.4% QoQ
Ownership
0.222%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#47
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clearbridge Investments, LLC holds $3,156,802,100 across 12 Drug Manufacturers - General names. JNJ ranks #1 (43.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
5,343,260 | $1,357,027,741 | |
| 2 | AZN |
Astrazeneca PLC
|
5,021,518 | $952,180,243 | |
| 3 | LLY |
ELI LILLY & Co
|
483,528 | $579,958,037 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,088,957 | $137,578,827 | |
| 5 | MRK |
Merck & Co., Inc.
|
565,690 | $72,691,165 | |
| 6 | AMGN |
Amgen Inc
|
69,065 | $25,009,817 | |
| 7 | ABBV |
AbbVie Inc.
|
82,422 | $20,740,672 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
101,597 | $5,854,019 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,357,027,741 | 5,343,260 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,380,459,499 | 5,647,437 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,160,785,032 | 5,609,012 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $989,344,009 | 5,335,692 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $822,663,077 | 5,385,683 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $974,733,886 | 5,877,556 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $836,979,861 | 5,787,442 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $980,351,664 | 6,049,313 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $879,740,547 | 6,019,024 | Shares | Defined | 2024-08-27 | |
| 2024-03-31 | $920,851,514 | 5,821,174 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $985,139,740 | 6,285,184 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $971,001,881 | 6,234,362 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,120,658,291 | 6,770,531 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $947,589,400 | 6,113,480 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,126,787,462 | 6,378,644 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $984,799,260 | 6,028,399 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,058,619,404 | 5,963,717 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,022,148,149 | 5,767,354 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,038,449,300 | 6,070,318 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,013,056,392 | 6,272,795 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,001,774,714 | 6,080,944 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,016,200,045 | 6,183,146 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $989,427,285 | 6,286,868 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $992,769,953 | 6,668,256 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $967,709,624 | 6,881,246 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $877,851,096 | 6,694,510 | Shares | Defined | 2020-05-22 | |
| No filing history on record for this holder in this stock. | ||||||